XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.24.3

Revenue | 9 Months Ended
--- | ---
Sep. 30, 2024
Revenue [Abstract] |
REVENUE | 14. REVENUE We primarily offer the First Defense Ò product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the three-month or nine-month periods ended September 30, 2024 or 2023. We do not have any contract assets for which we have satisfied the performance obligations, but do not yet have the right to bill for, or contract liabilities such as customer advances. All trade receivables on our balance sheet are from contracts with customers. We incur no material costs to obtain contracts. The following table presents our product sales disaggregated by geographic area:
|  | During the Three-Month Periods Ended September 30, |  |  | During the Nine-Month Periods Ended September 30, |
|  | 2024 |  |  | % |  |  | 2023 |  |  | % |  |  | 2024 |  |  | % |  |  | 2023 |  |  | % |
United States |  | $ | 5,216,401 |  |  |  | 87 | % |  | $ | 4,923,265 |  |  |  | 91 | % |  | $ | 16,449,178 |  |  |  | 88 | % |  | $ | 11,173,686 |  |  |  | 90 | %
Other |  |  | 795,172 |  |  |  | 13 | % |  |  | 473,235 |  |  |  | 9 | % |  |  | 2,292,862 |  |  |  | 12 | % |  |  | 1,202,022 |  |  |  | 10 | %
Total Product Sales |  | $ | 6,011,573 |  |  |  | 100 | % |  | $ | 5,396,500 |  |  |  | 100 | % |  | $ | 18,742,040 |  |  |  | 100 | % |  | $ | 12,375,708 |  |  |  | 100 | %
The following table presents our product sales disaggregated by major product category:
|  | During the Three-Month Periods Ended September 30, |  |  | During the Nine-Month Periods Ended September 30, |
|  | 2024 |  |  | % |  |  | 2023 |  |  | % |  |  | 2024 |  |  | % |  |  | 2023 |  |  | % |
First Defense® product line |  | $ | 5,951,344 |  |  |  | 99 | % |  | $ | 5,360,063 |  |  |  | 99 | % |  | $ | 18,602,053 |  |  |  | 99 | % |  | $ | 12,253,555 |  |  |  | 99 | %
Other animal health |  |  | 60,229 |  |  |  | 1 | % |  |  | 36,437 |  |  |  | 1 | % |  |  | 139,987 |  |  |  | 1 | % |  |  | 122,153 |  |  |  | 1 | %
Total Product Sales |  | $ | 6,011,573 |  |  |  | 100 | % |  | $ | 5,396,500 |  |  |  | 100 | % |  | $ | 18,742,040 |  |  |  | 100 | % |  | $ | 12,375,708 |  |  |  | 100 | %

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org/606/tableOfContent + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenuesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration